articleTop 1% cited

A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls

Schizophrenia Research · 2005 · Vol. 80(1) · pp. 45–53

Donald Goff✉(Massachusetts General Hospital)Lisa Sullivan(Harvard University Press)Joseph P. McEvoy(Harvard University)Jonathan M. Meyer(Massachusetts General Hospital)Henry A. Nasrallah(Harvard University)Gail L. Daumit(Massachusetts General Hospital)Steven Lamberti(Massachusetts General Hospital)Ralph B. D’Agostino(Harvard University)T. Scott Stroup(Massachusetts General Hospital)Sonia M. Davis(Massachusetts General Hospital)Jeffrey A. Lieberman(Harvard University Press)

View via DOI Publisher page

Schizophrenia research and treatment Cardiovascular Function and Risk Factors Cardiac Health and Mental HealthMedicineSchizophrenia (object-oriented programming)Internal medicineNational Health and Nutrition Examination SurveyAntipsychoticFramingham Risk ScoreDiabetes mellitusPopulationBody mass indexFramingham Heart Study

MeSH terms

AdolescentAdultAgedCoronary DiseaseDiabetes MellitusFemaleHumansHypertensionCholesterol, HDLMaleMiddle AgedRisk FactorsSchizophreniaSmokingAntipsychotic Agents

Citations

530

FWCI

16.24

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline